Furthermore, systemic treatment of EPO increased infiltration of CD11b(+) macrophages in tumor-draining lymph nodes and increased VEGF-C expression in lymph node-derived CD11b(+) macrophages, as well as in bone marrow-derived macrophages in a dose- and time-dependent manner (121). This evidence concerns the gene EPO and neoplasm.